Harrow, Inc. (NASDAQ:HROW) Shares Purchased by Teacher Retirement System of Texas

Teacher Retirement System of Texas increased its holdings in shares of Harrow, Inc. (NASDAQ:HROW) by 18.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,951 shares of the company’s stock after purchasing an additional 1,408 shares during the period. Teacher Retirement System of Texas’ holdings in Harrow were worth $300,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the stock. State Street Corp boosted its position in shares of Harrow by 2.2% in the third quarter. State Street Corp now owns 730,973 shares of the company’s stock worth $32,865,000 after buying an additional 15,554 shares during the period. Geode Capital Management LLC raised its holdings in shares of Harrow by 0.6% during the 3rd quarter. Geode Capital Management LLC now owns 722,730 shares of the company’s stock valued at $32,500,000 after buying an additional 3,960 shares during the period. Charles Schwab Investment Management Inc. lifted its position in Harrow by 1.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 255,218 shares of the company’s stock worth $8,563,000 after acquiring an additional 3,589 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Harrow by 443.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 238,367 shares of the company’s stock worth $10,717,000 after acquiring an additional 194,480 shares during the period. Finally, Wellington Management Group LLP grew its position in Harrow by 3.6% in the third quarter. Wellington Management Group LLP now owns 103,179 shares of the company’s stock valued at $4,639,000 after acquiring an additional 3,612 shares in the last quarter. 72.76% of the stock is currently owned by institutional investors and hedge funds.

Harrow Stock Performance

Shares of HROW opened at $24.98 on Wednesday. The firm has a market cap of $889.66 million, a price-to-earnings ratio of -26.57 and a beta of 0.69. The company has a quick ratio of 1.44, a current ratio of 1.55 and a debt-to-equity ratio of 3.23. The business’s 50 day moving average is $28.53 and its two-hundred day moving average is $37.72. Harrow, Inc. has a 52-week low of $9.86 and a 52-week high of $59.23.

Harrow (NASDAQ:HROW) last posted its quarterly earnings results on Thursday, March 27th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.11 by $0.14. The firm had revenue of $66.83 million for the quarter, compared to analysts’ expectations of $66.01 million. Harrow had a negative net margin of 19.75% and a negative return on equity of 45.57%. Analysts forecast that Harrow, Inc. will post -0.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on HROW. B. Riley reduced their target price on shares of Harrow from $69.00 to $65.00 and set a “buy” rating on the stock in a research report on Tuesday. HC Wainwright reiterated a “buy” rating and issued a $57.00 price objective on shares of Harrow in a report on Monday.

Harrow Company Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.